₹140.31
−2.43%NSE close, 16 Nov 2026
−5.06%
GPT Healthcare is a small cap company, listed on NSE under the symbol GPTHEALTH. At ₹140.31 a share, the market values the whole company at ₹1,151 crore.
In FY26, it reported sales of ₹473 crore and a net profit of ₹42 crore, an operating margin of 17.8%.
The market values the company at 22.1 times its profit over the last twelve months and 4.04 times its book value; its return on equity is 18.3% and its borrowings are 0.05 times its equity.
Promoters hold 65.57% of the shares. Foreign institutions hold 3.00%, and domestic institutions, mutual funds among them, 7.10%.
Over the past year the share price has fallen 3.5%, and it is 19.8% below its 52-week high.
₹ crore. Standalone figures: the company files no consolidated results.
Transcript
Link of Recording
Press Release on Un-Audited Financial Results for Q2 &H1 FY27
| Dec 2025 |
|---|
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 96.6 | 99.4 | 97.8 | 106 | 102 | 101 | 107 | 119 | 120 | 126 | 126 | 136 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 75.6 | 76.3 | 79.8 | 82.2 | 80.9 | 80.7 | 89.8 | 96.2 | 99.4 | 103 | 102 | 109 |
| Operating profit | 21.0 | 23.2 | 18.0 | 23.4 | 21.3 | 20.7 | 17.4 | 22.7 | 20.7 | 23.4 | 24.2 | 26.9 |
| Operating margin | 21.7% | 23.3% | 18.4% | 22.2% | 20.8% | 20.4% | 16.2% | 19.1% | 17.2% | 18.5% | 19.2% | 19.8% |
| Other income | 1.2 | 1.6 | 2.2 | 2.8 | 1.9 | 1.6 | 1.6 | 1.3 | 1.4 | 1.6 | 2.0 | 2.9 |
| Interest | 1.7 | 1.6 | 0.9 | 0.7 | 0.9 | 1.0 | 1.6 | 2.2 | 2.3 | 2.2 | 2.2 | 2.1 |
| Depreciation | 4.5 | 4.8 | 4.7 | 4.8 | 4.7 | 4.9 | 6.2 | 6.9 | 7.1 | 7.0 | 6.9 | 7.1 |
| Profit before tax | 16.0 | 18.4 | 14.7 | 20.7 | 17.6 | 16.4 | 11.1 | 15.1 | 12.8 | 15.9 | 17.2 | 20.7 |
| Tax | 4.5 | 5.6 | 4.7 | 5.9 | 5.4 | 3.5 | 3.4 | 4.5 | 3.4 | 1.3 | 4.4 | 5.3 |
| Net profit | 11.5 | 12.8 | 10.0 | 14.8 | 12.3 | 12.9 | 7.7 | 10.6 | 9.4 | 14.6 | 12.7 | 15.4 |
| EPS (₹) | 1.44 | 1.59 | 1.21 | 1.81 | 1.49 | 1.57 | 0.94 | 1.29 | 1.14 | 1.78 | 1.55 | 1.88 |
₹ crore, financial years to March.
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | 67.4 | 81.2 | 34.2 |
| From investing | −32.6 | −47.3 | −16.5 |
| From financing | −34.8 | −31.4 | −21.0 |
| Spent on fixed assets | −49.9 | −41.8 | −18.3 |
| Free cash flow | 17.5 | 39.3 | 16.0 |
Margins, returns, debt, tax and cash.
| Line | FY25 | FY26 |
|---|---|---|
| Net margin | 12.3% | 8.9% |
| Operating margin | 20.5% | 17.8% |
| Return on equity | 20.1% | 15.7% |
| Return on capital employed | 27.9% | 22.1% |
| Return on assets | 13.0% | 9.1% |
| Debt to equity | 0.05 | 0.06 |
| Interest coverage | 21.00 | 7.70 |
| Debt to assets | 0.03 | 0.03 |
| Current ratio | 1.06 | 1.12 |
| Quick ratio | 0.94 | 0.99 |
| Cash ratio | 0.02 | 0.05 |
| Asset turnover | 1.06 | 1.02 |
| Fixed asset turnover | 2.01 | 1.78 |
| Inventory turnover | 8.90 | 8.50 |
| Receivables turnover | 16.30 | 23.30 |
| Gross margin | 80.6% | 81.0% |
| Cash from operations to profit | 135.0% | 192.0% |
| Effective tax rate | 28.0% | 23.0% |
Record date for the purpose of Dividend is 12-Nov-2026.
Board of Directors at its meeting held on November 05, 2026, declared Interim Dividend of Rs. 1.00 per equity share.
The financial results for the period ended September 30, 2026.
Schedule of meet
Appointment of Cygnus Partners Private Limited for providing Investor Relations Advisory Services.
Schedule of meet
A copy Srutinizers report of Annual General Meeting held on August 06, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on August 06, 2026
Press Release on UFR for Q1FY2027
The financial results for the period ended Jun 30, 2026.